Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Migraine Nasal Spray Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.
The global migraine nasal spray market is expected to reach an estimated $621.6 million by 2030 with a CAGR of 6.5% from 2024 to 2030.
The future of the market looks promising with opportunities in the institutional sale and retail sale markets. The major drivers for this market are rising incidences of chronic diseases and stress, increasing efficiency of intranasal drug delivery to combat migraine, as well as, n aging population and a lifestyle of inactivity.
The study includes a forecast for the global migraine nasal spray by formulation, packaging, dosage, distribution channel, and region.
Migraine Nasal Spray Market by Formulation [Shipment Analysis by Value from 2018 to 2030]:
- Aqueous
- Hydroalcoholic
- Non-Aqueous Based Solutions
- Suspensions
- Emulsions
- Dry Powder/Microparticles
Migraine Nasal Spray Market by Packaging [Shipment Analysis by Value from 2018 to 2030]:
- Pressurized Cannisters
- Pump Bottles
Migraine Nasal Spray Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:
- Multi Dose
- Bi Dose
- Single/Unit Dose
Migraine Nasal Spray Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
- Institutional Sales
- Retail Sales
Migraine Nasal Spray Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Migraine Nasal Spray Market Insights
- Pump bottles will remain the larger segment over the forecast period due to the growing usage of dry films as protective coatings by significant manufacturers worldwide on a variety of substrates, including glass, metal, and plastic.
- North America will remain the largest region over the forecast period due to increasing investments in R&D for developing nasal sprays for treating various diseases, as well as, existence of major players in the region.
List of Migraine Nasal Spray Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies migraine nasal spray companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the migraine nasal spray companies profiled in this report include:
- Pfizer
- GlaxoSmithKline (GSK)
- AstraZeneca
- RENAISSANCE LAKEWOOD
Features of the Market Report
- Market Size Estimates: Migraine nasal spray market size estimation in terms of value ($M).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Migraine nasal spray market size by formulation, packaging, dosage, distribution channel, and region in terms of value ($M).
- Regional Analysis: Migraine nasal spray market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different formulation, packaging, dosage, distribution channel, and regions for the migraine nasal spray market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the migraine nasal spray market.
- Analysis of competitive intensity of the industry based on Porter's Five Forces model.
For more information about this report visit https://www.researchandmarkets.com/r/t1thoi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
